[go: up one dir, main page]

NO20006581D0 - Membran eller matriks for å regulere permeeringshastigheten for medikamenter - Google Patents

Membran eller matriks for å regulere permeeringshastigheten for medikamenter

Info

Publication number
NO20006581D0
NO20006581D0 NO20006581A NO20006581A NO20006581D0 NO 20006581 D0 NO20006581 D0 NO 20006581D0 NO 20006581 A NO20006581 A NO 20006581A NO 20006581 A NO20006581 A NO 20006581A NO 20006581 D0 NO20006581 D0 NO 20006581D0
Authority
NO
Norway
Prior art keywords
diaphragm
drugs
regulate
matrix
permeation rate
Prior art date
Application number
NO20006581A
Other languages
English (en)
Other versions
NO20006581L (no
NO327955B1 (no
Inventor
Harri Jukarainen
Tommi Markkula
Juha Ala-Sorvari
Matti Lehtinen
Jarkko Ruohonen
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO20006581D0 publication Critical patent/NO20006581D0/no
Publication of NO20006581L publication Critical patent/NO20006581L/no
Publication of NO327955B1 publication Critical patent/NO327955B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/10—Block- or graft-copolymers containing polysiloxane sequences
    • C08L83/12—Block- or graft-copolymers containing polysiloxane sequences containing polyether sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Silicon Polymers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Wrappers (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Materials For Medical Uses (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
NO20006581A 1998-06-30 2000-12-21 Membran eller matriks for a regulere permeeringshastigheten for medikamenter NO327955B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981506A FI107339B (fi) 1998-06-30 1998-06-30 Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
PCT/FI1999/000511 WO2000000550A1 (en) 1998-06-30 1999-06-11 A membrane or matrix for controlling the permeation rate of drugs

Publications (3)

Publication Number Publication Date
NO20006581D0 true NO20006581D0 (no) 2000-12-21
NO20006581L NO20006581L (no) 2000-12-29
NO327955B1 NO327955B1 (no) 2009-10-26

Family

ID=8552104

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006581A NO327955B1 (no) 1998-06-30 2000-12-21 Membran eller matriks for a regulere permeeringshastigheten for medikamenter

Country Status (28)

Country Link
EP (1) EP1124902B1 (no)
JP (1) JP2002519467A (no)
KR (1) KR100599868B1 (no)
CN (2) CN1269909C (no)
AR (1) AR018952A1 (no)
AT (1) ATE290049T1 (no)
AU (1) AU752895B2 (no)
BG (1) BG65148B1 (no)
BR (1) BR9911140B1 (no)
CA (1) CA2336149C (no)
CO (1) CO5060523A1 (no)
CZ (1) CZ299613B6 (no)
DE (1) DE69923992T2 (no)
EE (1) EE04685B1 (no)
ES (1) ES2237120T3 (no)
FI (1) FI107339B (no)
HU (1) HU229159B1 (no)
NO (1) NO327955B1 (no)
NZ (1) NZ508275A (no)
PE (1) PE20000935A1 (no)
PL (1) PL193485B1 (no)
PT (1) PT1124902E (no)
RU (1) RU2201794C2 (no)
SK (1) SK285325B6 (no)
TW (1) TWI237571B (no)
UA (1) UA71566C2 (no)
WO (1) WO2000000550A1 (no)
ZA (1) ZA200006986B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
EP1438942A1 (en) 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
ES2300048T3 (es) * 2004-08-25 2008-06-01 UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION Pelicula polimerica.
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
MX2009009708A (es) 2007-03-12 2009-09-24 Bayer Schering Pharma Oy Uso de tocoferol.
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
PT2349143E (pt) 2008-09-17 2013-07-08 Bayer Oy Um dispositivo de inserção
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
CN102068914B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
CN102008909B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
BR112014026086A2 (pt) 2012-04-23 2017-07-18 Bayer Pharma AG aplicação de 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas na terapia da menorragia, bem como sistemas intrauterinos contendo 18-metil-15beta,16beta-metilen-19-nor-20-spirox-4-en-3-onas para a terapia de distúrbios de sangramento uterino
TW201350122A (zh) 2012-04-23 2013-12-16 Bayer Pharma AG １８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內用途，包含１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內系統，及其於避孕及婦科治療之用途
WO2015055635A1 (en) * 2013-10-18 2015-04-23 Bayer Oy Intrauterine delivery system
US11096888B2 (en) 2015-05-13 2021-08-24 Bayer Oy Long acting drug delivery device and its use in contraception
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
WO2019119059A1 (en) 2017-12-22 2019-06-27 Alyra Biotech Pty Ltd Treatment of pain and/or pain related symptoms associated with dysmenorrhea
EP3536735B1 (de) * 2018-03-05 2020-10-14 Evonik Operations GmbH Vernetzte polyether-siloxan block-copolymere sowie deren verwendung zur herstellung von polyurethanschaumstoffen
EP3976013A4 (en) 2019-05-31 2023-05-31 Alyra Biotech Pty Ltd METHODS, COMPOSITIONS AND DEVICES FOR THE TREATMENT OF NEUROINFLAMMATORY CONDITIONS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889108A (en) * 1997-06-02 1999-03-30 Dow Corning Corporation Thickening solvents with elastomeric silicone polyethers

Also Published As

Publication number Publication date
EP1124902B1 (en) 2005-03-02
AR018952A1 (es) 2001-12-12
BG65148B1 (bg) 2007-04-30
CO5060523A1 (es) 2001-07-30
CN1269909C (zh) 2006-08-16
CN1308653A (zh) 2001-08-15
WO2000000550A1 (en) 2000-01-06
HUP0102600A3 (en) 2004-04-28
FI981506L (fi) 1999-12-31
SK18942000A3 (sk) 2001-07-10
ATE290049T1 (de) 2005-03-15
NO20006581L (no) 2000-12-29
NO327955B1 (no) 2009-10-26
BG105081A (en) 2001-09-28
AU4783999A (en) 2000-01-17
EP1124902A1 (en) 2001-08-22
FI981506A0 (fi) 1998-06-30
KR100599868B1 (ko) 2006-07-12
SK285325B6 (sk) 2006-11-03
DE69923992T2 (de) 2006-04-13
CZ299613B6 (cs) 2008-09-17
ZA200006986B (en) 2001-05-23
RU2201794C2 (ru) 2003-04-10
PT1124902E (pt) 2005-07-29
DE69923992D1 (de) 2005-04-07
PE20000935A1 (es) 2000-09-18
TWI237571B (en) 2005-08-11
EE04685B1 (et) 2006-08-15
BR9911140B1 (pt) 2009-08-11
KR20010053346A (ko) 2001-06-25
HU229159B1 (hu) 2013-09-30
ES2237120T3 (es) 2005-07-16
CA2336149C (en) 2007-01-02
PL193485B1 (pl) 2007-02-28
PL345103A1 (en) 2001-12-03
CN1176999C (zh) 2004-11-24
FI107339B (fi) 2001-07-13
CZ20004749A3 (cs) 2001-10-17
CA2336149A1 (en) 2000-01-06
CN1488678A (zh) 2004-04-14
UA71566C2 (uk) 2004-12-15
HUP0102600A2 (hu) 2001-11-28
NZ508275A (en) 2002-09-27
JP2002519467A (ja) 2002-07-02
HK1038939A1 (en) 2002-04-04
AU752895B2 (en) 2002-10-03
BR9911140A (pt) 2001-03-06
EE200000788A (et) 2002-04-15

Similar Documents

Publication Publication Date Title
NO20006581D0 (no) Membran eller matriks for å regulere permeeringshastigheten for medikamenter
EE200100257A (et) Uudne membraan või maatriks ravimi läbitungimise kontrollimiseks
DE69623116D1 (de) Gasdurchlässiges membran
DE19882417T1 (de) Nichtporöse, gasdurchlässige Membran
DE60018814D1 (de) Nähbare Membran zur Adhäsionsverhinderung
DE59912948D1 (de) Membran zur Trennung von Fluiden
IT1284337B1 (it) Struttura di membrana sopportata
NO913738D0 (no) Membransepareringssystem og fremgangsmaate til drift av samme.
DE3771111D1 (de) Zusammengesetzte membran.
DE60044178D1 (de) Herstellung einer dünnen membran
FI924418A7 (fi) Blaosor av syntetisk membran som innehaoller funktionellt aktiva fusionspeptider som laekemedel befriande system
DE69112149D1 (de) Durchlässige biokompatible Membran.
ID20805A (id) Pengelektrolisa dwipolar membran penukar ion
DE69209273D1 (de) Permselektive polyacrylnitrilcopolymermembran und ihre herstellung
FI964445L (fi) Komposiittimembraani kemiallista synteesiä varten
ID17240A (id) Membran penutupan
EP1180042A4 (en) MODEL MEMBRANE SYSTEMS
DE69705185D1 (de) Protonen leitende Membran
DE69005198D1 (de) Selektivdurchlässige Membran.
DE69924472D1 (de) Selektion von reifem sperma durch membranoberflächen-determinanten
DE60011724D1 (de) Membran mit Honigwabenstruktur zur Gastrennung
NO20014081L (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
DE10083517T1 (de) Atmungsaktive Gebäudemembrane
DE3778237D1 (de) Membran fuer lautsprecher.
EP1274723A4 (en) ACTIVATION OF PEPTIDE PRODRUGS BY hK2

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees